Ocugen secures $22.5 million in a funding round led by RTW Investments, extending its financial runway into 2026 and supporting its clinical development efforts.
Amount Raised
$22.5 Million
Round Type
Post-IPO Equity
MalvernBiotechnologyHealthcareHealth CareTherapeuticsInvestors
Description
Ocugen announced a direct stock offering that generated gross proceeds of $22.5 million. The funding will support its key initiatives, following encouraging Phase 2 results for its gene therapy candidate targeting geographic atrophy. The net proceeds will extend its liquidity runway into the fourth quarter of 2026. This financing represents a critical capital infusion to support ongoing operations.
Quick answer
Ocugen raised $22.5 Million in a Post-IPO Equity round, dated January 26, 2026. Investors: RTW Investments. Ocugen is based in Malvern, Pennsylvania, United States.
- How much did Ocugen raise?
- Ocugen raised $22.5 Million in a Post-IPO Equity round on January 26, 2026.
- Who invested in Ocugen?
- RTW Investments is named as investors in this round.
- What does Ocugen do?
- Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe.
- Where is Ocugen based and how big is it?
- Ocugen is based in Malvern, Pennsylvania, United States. Fundz records about 137 employees.
- Who are the decision-makers at Ocugen?
- Fundz holds 2 contacts at Ocugen, including the AVP, Manufacturering Operations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Ocugen that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $2M on March 4, 2026.
- Change Agents Corporation. raised $207K (Debt Financing) on February 25, 2026.
- Korsana Biosciences raised $175M (Series A) on February 18, 2026.
- CytoDyn raised $19M on January 30, 2026.
- Os Therapies raised $3.5M on January 14, 2026.
- Tessera Defense & Homeland Security Inc. raised $3.3M on January 13, 2026.
Who to call at Ocugen, and when
A new round usually means Ocugen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ocugen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ocugen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ocugen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ocugen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ocugen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.